Abstract
Disease name and synonyms
It is called Berardinelli-Seip syndrome after Berardinelli from Brazil described the first patients in 1954. The syndrome was confirmed in 1959 in Norway were Seip described a new series of patients originating from the county of Rogaland. In the European literature, the terms generalized lipodystrophy, congenital lipodystrophy or total lipodystrophy have also been coined. Seip syndrome, or Lawrence syndrome have also been used, although the latter designates in principle the so-called acquired form. it is usually called lipoatrophic diabetes in the United States. It has received the OMIM number 269700. Brunzell syndrome is the association of bone cysts and lipoatrophic diabetes described in five affected AfricanAmericans from the same sibship. A separate OMIM entry (272500) was given but it is now generally admitted that bone cysts represent a rare complication of Berardinelli-Seip congenital lipodystrophy (BSCL). 
Excluded diseases

Clinical description
Neonatal or infantile presentation
Severe forms may be of prenatal onset with intrauterine growth retardation. When diagnosed at birth (rare), it is usually because of lipoatrophy. Reason for referral in the first months of life include failure to thrive, or conversely gigantism, hepatomegaly, lipoatrophy, facial dysmorphia, enlarged tongue or developmental delay.
Juvenile presentation
Accelerated growth, lipoatrophy or cognitive impairment are major modes of presentation in early childhood while diabetes mellitus manifested by weight loss, polydipsy, polyuria or asthenia is frequently the cause in the second decade.
Van Maldergem, L., Berardinelli-Seip congenital lipodystrophy. Orphanet encyclopedia. November 2001.
http://www.orpha.net/data/patho/GB/uk-berard.pdf
Adult presentation
Presents rarely in early adulthood with diabetes mellitus. The plastic surgery clinic for cosmetic improvement of facial lipoatrophy, the cardiologic clinics or gastroenterologic clinics may be also the first through which the patient comes to medical attention.
Management
Diagnostic work-up
Family history, including a three generation pedigree and the locality of origin of the grandparents needs to be investigated. Specific questions on parental consanguinity should be asked for. Clinical examination includes the pubertal status according to Tanner's charts, a complete neurological examination and search for signs of liver dysfunction and cardiac failure. Attention must also be paid to possible orthopedics problems (reduced hip mobility, genu valgum). A majority of patients (two-thirds) mentally retarded, especially those with a nonsense or a splice-site mutation affecting the first half of the gene. Missense mutations reportedly less harmful. In a recent survey of 45 BSCL2 patients, 7 premature deaths were observed, from heart and liver failure. Through the study of patients from an international consortium, a gene has been cloned in 2001. It encodes a protein of unknown function, mainly expressed in the brain, termed seipin (Magré et al 2001) BSCL3:some rare families appear unlinked to neither 11q13 nor 9q34. If we also consider a patient with unconclusive segregation study, it seems associated with a severe phenotype (two premature deaths at 16 months and 7 years in two Czech patients). However, these are very scarce data and awaits confirmation on additional families
Addtitional investigations
Diagnostic methods
Dysmorphology Clinical examination Blood chemistry
Genetic counseling
Recurrence risk 25% Microsatellites segregation study and mutation screening mandatory to refine counseling. Van http://www.orpha.net/data/patho/GB/uk-berard.pdf
Prenatal diagnosis
Based on the identification of the mutation in the index patients or carriers. Chorionic Villus Sampling between 9 and 12 weeks. Ethical issue of terminating a pregnancy for the apparently milder BSCL1 subtype where mental retardation is rare. http://www.orpha.net/data/patho/GB/uk-berard.pdf
Unresolved questions
